SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-23-000059
Filing Date
2023-02-10
Accepted
2023-02-10 17:23:00
Documents
1
Group Members
NEA 13 GP, LTDNEA PARTNERS 10, LIMITED PARTNERSHIPNEA PARTNERS 13, L.P.NEW ENTERPRISE ASSOCIATES 13, L.P.SCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#1) nea10-glyco_18697.htm SC 13D/A 301866
  Complete submission text file 0001072613-23-000059.txt   303416
Mailing Address
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 4102440115
NEW ENTERPRISE ASSOCIATES 10 L P (Filed by) CIK: 0001132326 (see all company filings)

IRS No.: 061590878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Subject) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87811 | Film No.: 23613536
SIC: 2834 Pharmaceutical Preparations